Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Raw Materials (2016 - 2018)

Lifecore Biomedical, Inc. \De\ (LFCR) has 7 years of Raw Materials data on record, last reported at $14.6 million in Q4 2018.

  • For Q4 2018, Raw Materials rose 10.42% year-over-year to $14.6 million; the TTM value through Nov 2018 reached $14.6 million, up 10.42%, while the annual FY2018 figure was $15.3 million, 50.48% up from the prior year.
  • Raw Materials reached $14.6 million in Q4 2018 per LFCR's latest filing, up from $13.9 million in the prior quarter.
  • Across five years, Raw Materials topped out at $15.3 million in Q2 2018 and bottomed at $4.2 million in Q4 2016.
  • Average Raw Materials over 5 years is $11.2 million, with a median of $10.9 million recorded in 2014.
  • Peak YoY movement for Raw Materials: crashed 62.27% in 2016, then surged 215.73% in 2017.
  • A 5-year view of Raw Materials shows it stood at $12.1 million in 2014, then decreased by 8.15% to $11.1 million in 2015, then plummeted by 62.27% to $4.2 million in 2016, then soared by 215.73% to $13.2 million in 2017, then rose by 10.42% to $14.6 million in 2018.
  • Per Business Quant database, its latest 3 readings for Raw Materials were $14.6 million in Q4 2018, $13.9 million in Q3 2018, and $15.3 million in Q2 2018.